Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Vivaldi Coelho Rogerio

Over the trailing 90 days, Vivaldi Coelho Rogerio (Director at Crinetics Pharmaceuticals, Inc.) sold $120K of stock in CRNX, per 3 SEC Form 4 transactions.

Role
Director
Companies
CRNX
Window
Trailing 90 days · 3 transactions · CIK 1610381
Net activity
−$120K ($0 bought · $120K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
CRNXCrinetics Pharmaceuticals, Inc.3$120K−$120K

Transactions (3)

DateSymbolTypeSharesValueDescription
2026-07-02CRNXSell3.0K$120KOpen market or private sale
2026-06-18CRNXBuy9.7K$0Grant, award or other acquisition
2026-06-18CRNXBuy5.9K$0Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Vivaldi's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free